Yu Zheng - Melrose MA, US Richard J. Roberts - Wenham MA, US
Assignee:
New England Biolabs, Inc. - Ipswich MA
International Classification:
C12Q 1/00 C12Q 1/68 C12P 21/06
US Classification:
435 4, 435 61, 435 691
Abstract:
Compositions and methods are provided for selection and enrichment of a target gene from a library of polynucleotide sequences such as might be formed from a genome or by random mutagenesis of a genetic sequence. The selection and enrichment occurs in aqueous droplets formed in an emulsion that compartmentalize individual polynucleotides from the library or a plurality of polynucleotides that may include polynucleotides not derived from the library, transcription and translation reagents and optionally additional chemical and enzyme reagents. The selection and enrichment method utilizes a polynucleotide adaptor which when ligated to the polynucleotide fragment enables amplification to occur in the presence of an adaptor specific primer.
Selection And Enrichment Of Proteins Using In Vitro Compartmentalization
Compositions and methods are provided for selection and enrichment of a target gene from a library of polynucleotide sequences such as might be formed from a genome or by random mutagenesis of a genetic sequence. The selection and enrichment occurs in aqueous droplets formed in an emulsion that compartmentalize individual polynucleotides from the library or a plurality of polynucleotides that may include polynucleotides not derived from the library, transcription and translation reagents and optionally additional chemical and enzyme reagents. The selection and enrichment method utilizes a polynucleotide adaptor which when ligated to the polynucleotide fragment enables amplification to occur in the presence of an adaptor specific primer.
Compositions, Methods And Related Uses For Cleaving Modified Dna
Compositions, methods and related uses are provided relating to cleaving modified DNA. For example, a set of DNA fragments obtainable by enzymatic cleavage of a large DNA is described where at least 50% are similarly sized and have a centrally positioned modified nucleotide. In addition, an enzyme preparation is provided that includes one or more enzymes that recognize a modified nucleotide in a DNA and cleave the DNA at a site that is at a non-random distance from the modified nucleotide. The one or more enzymes are further characterized by an N-terminal conserved domain with greater than 90% amino acid sequence homology to WXD(X)YXGD. The related uses include creating a methylome, methods of purifying DNA fragments containing a modified nucleotide and diagnostic applications.
Detection And Quantification Of Hydroxymethylated Nucleotides In A Polynucleotide Preparation
Jurate Bitinaite - Rowley MA, US Romualdas Vaisvila - Ipswich MA, US Sriharsa Pradhan - Wenham MA, US Yu Zheng - Topsfield MA, US Richard J. Roberts - Wenham MA, US Christopher Noren - Boxford MA, US Elisabeth A. Raleigh - Somerville MA, US Geoffrey Wilson - South Hamilton MA, US
Assignee:
NEW ENGLAND BIOLABS, INC. - Ipswich MA
International Classification:
C12Q 1/68
US Classification:
435 611
Abstract:
Methods and compositions are described for detecting hydroxymethylated nucleotides (hmNs) in a polynucleotide preparation with a view to mapping the location of hmNs in a genome, quantifying the occurrence of hmNs at selected loci and correlating the occurrence of hmNs with gene expression and phenotypic traits. Embodiments describe the use of modifying enzymes together with site-specific endonucleases to detect the hmNs.
Compositions, Methods And Related Uses For Cleaving Modified Dna
Yu Zheng - Topsfield MA, US Richard J. Roberts - Wenham MA, US
Assignee:
NEW ENGLAND BIOLABS, INC. - Ipswich MA
International Classification:
C40B 40/06
US Classification:
506 16
Abstract:
Compositions, methods and related uses are provided relating to cleaving modified DNA. For example, a set of DNA fragments obtainable by enzymatic cleavage of a large DNA is described where at least 50% are similarly sized and have a centrally positioned modified nucleotide. In addition, an enzyme preparation is provided that includes one or more enzymes that recognize a modified nucleotide in a DNA and cleave the DNA at a site that is at a non-random distance from the modified nucleotide. The one or more enzymes are further characterized by an N-terminal conserved domain with greater than 90% amino acid sequence homology to WXD(X)YXGD. The related uses include creating a methylome, methods of purifying DNA fragments containing a modified nucleotide and diagnostic applications.
Compositions, Methods And Related Uses For Cleaving Modified Dna
Zhenyu Zhu - Beverly MA, US Yu Zheng - Topsfield MA, US Shengxi Guan - Stoneham MA, US Hua Wang - Topsfield MA, US Aine Quimby - Newton NH, US Penghua Zhang - Lexington MA, US Lynne Apone - Waltham MA, US
Assignee:
NEW ENGLAND BIOLABS, INC. - Ipswich MA
International Classification:
C12Q 1/68 C12N 9/16
US Classification:
435 611, 435196
Abstract:
Compositions, methods and a kit are described relating to a novel family of enzymes which preferentially bind to a hydroxymethylated cytosine or a glucosylated hydroxymethylated cytosine and cleave double-stranded DNA at a defined distance 3′ of the recognition site to produce a cleavage fragment with a 1-3 base overhang.
Detection And Quantification Of Hydroxymethylated Nucleotides In A Polynucleotide Preparation
- Ipswich MA, US Romualdas Vaisvila - Ipswich MA, US Sriharsa Pradhan - Wenham MA, US Yu Zheng - Topsfield MA, US Richard J. Roberts - Wenham MA, US Christopher Noren - Boxford MA, US Elisabeth A. Raleigh - Somerville MA, US Geoffrey Wilson - South Hamilton MA, US
Assignee:
NEW ENGLAND BIOLABS, INC. - Ipswich MA
International Classification:
C12Q 1/68
Abstract:
Methods and compositions are described for detecting hydroxymethylated nucleotides (hmNs) in a polynucleotide preparation with a view to mapping the location of hmNs in a genome, quantifying the occurrence of hmNs at selected loci and correlating the occurrence of hmNs with gene expression and phenotypic traits. Embodiments describe the use of modifying enzymes together with site-specific endonucleases to detect the hmNs.
Vertex Pharmaceuticals
Research Scientist Ii
Massachusetts General Hospital Sep 2012 - May 2017
Hhmi Postdoctoral Fellow
Education:
University of Illinois at Chicago 2005 - 2012
Doctorates, Doctor of Philosophy, Molecular Biology, Biology, Philosophy
Fudan University 2001 - 2005
Bachelors, Bachelor of Science, Biological Science
Skills:
Molecular Biology Immunohistochemistry Biochemistry Cell Biology Cell Culture Molecular Cloning Immunofluorescence Transfection Western Blotting Animal Models Rna Isolation Fluorescence Microscopy Confocal Microscopy Flow Cytometry Rt Pcr Genetics Cell Signaling Cancer Research Crispr Pcr Microscopy Tissue Culture Qpcr Cell Protein Expression Circulating Tumor Cell Isolation Single Cell Rna Seq Rna In Situ Hybridization Nextgen Sequencing Bioinformatic Analysis Rnai
Interests:
Science and Technology Education Environment Health